Covered recipient · General Payments record
MURTADHA ABDULHUSSEIN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Behavioral Neurology & Neuropsychiatry
General Payments · PY2022–2024
$508.01
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $193.17 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $47.62 | 2 |
| Lundbeck LLC | $41.67 | 2 |
| Indivior Inc. | $37.43 | 2 |
| Otsuka America Pharmaceutical, Inc. | $20.35 | 1 |
| Teva Pharmaceuticals USA, Inc. | $16.56 | 1 |
| Axsome Therapeutics, Inc. | $15.69 | 1 |
| Supernus Pharmaceuticals, Inc. | $13.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.19 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103164838 | CMS |
| ABBVIE INC. | $25.43 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103164840 | CMS |
| Axsome Therapeutics, Inc. | $15.69 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148307358 | CMS |
| Indivior Inc. | $23.78 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144522745 | CMS |
| Indivior Inc. | $13.65 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144522747 | CMS |
| Lundbeck LLC | $15.96 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145888390 | CMS |
| Lundbeck LLC | $25.71 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145888392 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.35 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118847182 | CMS |
| Supernus Pharmaceuticals, Inc. | $13.85 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147884030 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.56 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151574021 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.